By Canadian Press

Canada announces partnership with India-based company to secure more AstraZeneca jabs

Feb 26, 2021 | 11:03 AM

Canada’s vaccine rollout received a significant boost Friday with the approval of a third COVID-19 inoculation, and Prime Minister Justin Trudeau announced another partnership with an India-based institute that will deliver two million additional doses of the newly authorized jab to Canadians by the spring.

Trudeau spoke on Friday hours after Health Canada announced it had approved a COVID-19 vaccine from AstraZeneca. 

The new partnership also means Canada will receive two million doses of the CoviShield vaccine, which is the same as AstraZeneca’s product, through an agreement with Mississauga, Ont.’s Verity Pharmaceuticals and the Serum Institute of India.

Trudeau says the first shipment of half a million of CoviShield doses will arrive by March.

Health Canada’s chief medical adviser Dr. Supriya Sharma said in a briefing Friday that the CoviShield and AstraZeneca products are “for all intents and purposes” the same vaccine.

Raiders AGM

Raiders impact on Prince Albert local economy continues to go up: AGM report

2h ago

Court proceedings

'The impact of this trauma will echo for generations': court case surrounding La Ronge woman's death reaches conclusion

Dec 11, 2024

Going Global

P.A.'s Zablocki named to Team Canada for U18 Women's World Championships

Dec 11, 2024

The difference is in where they are manufactured, she said, using the analogy of the same recipe made in two different kitchens. 

The two million doses of CoviShield are in addition to the 20 million doses Canada already secured with AstraZeneca that will start arriving in the spring.

Trudeau said as vaccinations ramp up across the country, many provinces have expanded the number of health professions able to administer a COVID-19 vaccine, and he asked for dentists, midwives, pharmacy technicians and retired nurses to lend a hand in the rollout.

This report by The Canadian Press was first published Feb. 26, 2021.

Melissa Couto Zuber, The Canadian Press